|
|
 |
|
David W. Carter, Director
Chairman and Chief Executive Officer, Xenogen Corporation
Mr. Carter has served as a director of Cell Genesys since May 1997.
Mr. Carter has served as chairman of the board of directors of Xenogen
Corporation since November 1997 and currently serves as chief executive
officer. Previously, Mr. Carter served as president, chief executive
officer and chairman of the board of directors of Somatix Therapy
Corporation. Prior to 1991, he was president and chief operating officer
of Northfield Laboratories. Mr. Carter also serves as a director of
Immunogen, Inc. Mr. Carter received a B.A. and an M.B.A. from Indiana
University. |
|
|
|
